Combining clinical predictors to better predict for the no-reflow phenomenon.

CONCLUSIONS: We have found that the combination of a CHA2DS2-VASc score and a pre-PCI thrombus load score was more sensitive in detecting the no-reflow phenomenon than only a CHA2DS2-VASc score in patients who underwent PPCIs for STEMIs.
PMID: 30070335 [PubMed - in process]

Source: Pharmacological Reviews - August 1, 2018 Category: Drugs & Pharmacology Authors: Avci E, Yildirim T, Aydin G, Kiris T, Dolapoglu A, Kadi H, Safak O, Bayata S Tags: Eur Rev Med Pharmacol Sci Source Type: research